Dihydropyridine calcium channel blockers: a rare and reversible cause of hepatotoxicity with cholestasis in a CAPD patient

被引：6
|
作者：
Basile, C [1 ]
Mascia, E
机构：
[1] Hosp Martina Franca, Nephrol Unit, Martina Franca, Italy
[2] Mil Hosp, Dept Surg, Taranto, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 11期
关键词：
D O I：
10.1093/ndt/14.11.2776
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2776 / 2777
页数：2
相关论文
共 50 条
  • [41] AN ANTIBODY TO DIHYDROPYRIDINE CALCIUM ENTRY BLOCKERS - A COMPARISON WITH THE CALCIUM-CHANNEL RECEPTOR IN SKELETAL-MUSCLE
    THAYER, SA
    PHAM, DH
    SCHULTZ, CM
    MINASKANIAN, G
    FAIRHURST, AS
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) : 4479 - 4485
  • [42] Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers
    von Vigier, RO
    Fossali, E
    Edefonti, A
    Vogt, B
    Bianchetti, MG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (03) : 334 - 335
  • [43] NEGATIVE-ION MASS-SPECTRA OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    EHRHARDT, JD
    ZIEGLER, JM
    BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1988, 15 (10): : 525 - 528
  • [44] Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets
    Kawabe, Yuki
    Nakamura, Haruyuki
    Hino, Eri
    Suzuki, Shigeo
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (03) : 618 - 624
  • [45] Serum uric acid change in relation to antihypertensive therapy with the dihydropyridine calcium channel blockers
    Zhang, Di
    Huang, Qi-Fang
    Sheng, Chang-Sheng
    Li, Yan
    Wang, Ji-Guang
    BLOOD PRESSURE, 2021, 30 (06) : 395 - 402
  • [46] Two carbamoyl-substituted dihydropyrimidines: potential mimics of dihydropyridine calcium channel blockers
    Ravikumar, K
    Sridhar, B
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2005, 61 : O41 - O44
  • [47] A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity
    Dietz, Jessica D.
    Du, Sarah
    Bolten, Charles W.
    Payne, Maria A.
    Xia, Chunsheng
    Blinn, James R.
    Funder, John W.
    Hu, Xiao
    HYPERTENSION, 2008, 51 (03) : 742 - 748
  • [48] Analysis of dihydropyridine calcium channel Blockers using negative ion photoionization mass spectrometry
    Pereira, Alberto S.
    Bicalho, Beatriz
    Ilha, Jaime O.
    De Nucci, Gilberto
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, 46 (01) : 35 - 41
  • [49] YAWNING INDUCED BY APOMORPHINE, PHYSOSTIGMINE OR PILOCARPINE IS POTENTIATED BY DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    BOURSON, A
    MOSER, PC
    PSYCHOPHARMACOLOGY, 1990, 100 (02) : 168 - 172
  • [50] Fortnightly review - Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: Is there a risk?
    Beevers, DG
    Sleight, P
    BRITISH MEDICAL JOURNAL, 1996, 312 (7039): : 1143 - 1145
12345